HEDIS Results
Molina’s scores are below. You can see how Molina performs compared to our target goal.
|
Measure / Data Element |
2020 |
2020 Goal |
|
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
53.21% |
67.47% |
|
Adult BMI Assessment (ABA) |
NA |
93.67% |
|
Annual Dental Visits (ADV) Total |
59.62% |
64.11% |
|
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
66.27% |
40.95% |
|
Appropriate Testing for Pharyngitis (CWP) |
72.75% |
86.51% |
|
Appropriate Treatment for Upper Respiratory Infection (URI) |
71.40% |
94.88% |
|
Asthma Medication Ratio (AMR) Total |
NA |
68.52% |
|
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) Total |
44.87% |
41.07% |
|
Breast Cancer Screening (BCS) |
NA |
63.98% |
|
Cervical Cancer Screening (CCS) |
45.26% |
66.49% |
|
Childhood Immunization Status (CIS) Combination #10 |
NA |
42.02% |
|
Chlamydia Screening in Women (CHL) Total |
53.91% |
66.24% |
|
Comprehensive Diabetes Care (CDC) BP Control < 140/90 |
55.43% |
71.44% |
|
Comprehensive Diabetes Care (CDC) HbA1c Control < 8.0% |
36.05% |
55.96% |
|
Comprehensive Diabetes Care (CDC) Eye Exam |
53.88% |
64.72% |
|
Controlling High Blood Pressure (CBP) |
46.72% |
66.91% |
|
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
77.90% |
84.27% |
|
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
2.56% |
16.93% |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
17.26% |
49.65% |
|
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
25.95% |
42.69% |
|
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
NA |
62.69% |
|
Immunizations for Adolescents (IMA) Combination #2 |
14.38% |
40.39% |
|
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
7.04% |
18.12% |
|
Medication Management for People with Asthma (MMA) Medication Compliance 75% Total |
NA |
42.77% |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total |
25.00% |
40.90% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
60.00% |
75.38% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
77.65% |
87.93% |
|
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
99.03% |
87.59% |
|
Prenatal and Postpartum Care (PPC) Postpartum Care |
69.34% |
69.83% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
NA |
81.24% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
NA |
69.97% |
|
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
NA |
67.19% |
|
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
NA |
66.42% |
|
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
62.41% |
66.58% |
|
Use of Imaging Studies for Low Back Pain (LBP) |
81.02% |
76.02% |
|
Use of Opioids at High Dosage (HDO) |
BR |
≤ 2.27% |
|
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
BR |
≤ 2.14% |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
57.91% |
85.16% |
NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate